TT medic joins forces with Trill Impact to accelerate growth

The MedTech development and manufacturing partner for high-quality polymer components, has entered a partnership with Trill Impact.

Image 6

TT medic, a MedTech development and manufacturing partner for high-quality polymer components operating in Austria, Switzerland and Germany, has entered a partnership with Trill Impact to accelerate growth.

TT medic is active in precision medical injection molding, specializing as a contract development and manufacturing organization (CDMO) in clean room processing of high-quality polymer components. The company covers almost the entire value chain, allowing to position itself as a fully integrated partner for MedTech OEMs. Strong engineering and R&D capabilities allows TT medic to support clients at an early stage of their product development and thus foster product innovation.

TT medic caters its products to several indications and therapeutic areas, including minimally invasive surgery, wound care, surgical sealants, drug delivery and ophthalmology. The product portfolio spans from blades and fibrin sealants to high-pressure check valves, contributing to patient safety and improved medical outcomes across critical therapeutic areas. The customer base includes global, industry-leading MedTech OEMs with whom TT medic has maintained long-term relationships.

The Austrian-headquartered group was established through the gradual combination of three successful family-owned businesses in the DACH region (GOLLER Systems, Renggli and j. Söllner) and has evolved into a dynamic MedTech CDMO platform. As a group, TT medic has been able to position itself as a trusted partner with a diversified customer base, through differentiated quality and regulatory competencies as well as strong clean room and injection molding capabilities.

Korbinian Knoblach, Partner and Co-Head of Private Equity at Trill Impact Advisory, says::

“We were impressed by TT medic’s position as an integrated partner of its global OEM customers, often acknowledged as part of the product development team within their specialized field of high-quality polymers. We’re looking forward to building on the successful growth of TT medic in our joint partnership.”

Kurt Helletzgruber, CEO of TT medic, says:

"We are excited to join forces with Trill Impact, as they have the abilities to support our continuous journey towards growing our businesses – aiming at scaling our positive impact.”


This material has been prepared for informational purposes only and should not be considered to be a recommendation to buy or sell securities or as investment advice. All statements and opinions included herein are subject to change as economic and market conditions dictate. There can be no assurance that any views, outlooks, or forward-looking statements will come to pass.

SDG and Impact contribution

TT medic’s products aim to contribute to patient safety and improved treatment outcomes in critical medical procedures. The concrete contribution varies by product, e.g., plastic blades reduce contamination risks, while ophthalmic handpieces improve precision in eye surgeries. TT medic’s offering from development and (re)design to manufacturing and regulatory services allows for product innovation and improvements in healthcare. TT medic has a company-wide contribution to SDG 3.8: Achieve universal health coverage, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all.




Related information

Trill Impact is a pioneering Impact House with around EUR 1.2 billion in assets under management across its investment strategies, Impact Private Equity, Impact Ventures and Microfinance, with a team of around 55 experienced professionals based in the Nordics, Germany, Luxembourg and USA. Trill Impact aims to become a force for positive change through impact private investments, delivering Real Returns and Lasting Impact for the benefit of investors, businesses and society at large - encouraging others to follow. For more information, please visit: www.trillimpact.com

TT medic GmbH operates in precision medical injection molding, specializing as a as a contract development and manufacturing organization (CDMO) in clean room processing of high-quality polymer components. The company caters to several indications, including minimally invasive surgery, wound care, surgical sealants, drug delivery and ophthalmology, contributing to patient safety and improved medical outcomes across critical therapeutic areas. For more information, please visit: www.tt-medic.com


Media contacts

Trill Impact

Karin Källén, Communication Manager

TT medic GmbH

Kurt Helletzgruber, CEO

Cookies

This website uses cookiesfor statistics and user experience.

This website uses cookies to improve your user experience, to provide a basis for improvement and further development of the website and to be able to direct more relevant offers to you. Feel free to read ours privacy policy. If you agree to our use, choose Accept all. If you want to change your choice afterwards, you will find that option at the bottom of the page.